Russell Investments Group
ORIC icon

Russell Investments Group’s Oric Pharmaceuticals ORIC Stock Holding History

Russell Investments Group’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.33M Buy
263,059
+56,022
+27% +$636K ﹤0.01% 1583
2025
Q4 		$1.69M Buy
207,037
+202,063
+4,062% +$2.33M ﹤0.01% 1965
2025
Q3 		$59.7K Buy
+4,974
New +$52.3K ﹤0.01% 3207
2024
Q3 		– Sell
-1,105
Closed -$7.81K – 3765
2024
Q2 		$7.81K Buy
+1,105
New +$9.89K ﹤0.01% 3130
2023
Q4 		– Sell
-28
Closed -$169 – 3281
2023
Q3 		$169 Buy
+28
New +$229 ﹤0.01% 3502
2022
Q2 		– Sell
-1,004
Closed -$5K – 2947
2022
Q1 		$5K Hold
1,004
– – ﹤0.01% 2728
2021
Q4 		$14K Hold
1,004
– – ﹤0.01% 2965
2021
Q3 		$20K Buy
+1,004
New +$20.4K ﹤0.01% 2997

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Russell Investments Group's ORIC Position: Q1 2026 in Review

Russell Investments Group increased its Oric Pharmaceuticals (ORIC) stake by 27% in Q1 2026, buying an estimated $636K and bringing the position to 263,059 shares worth $3.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1583.

Russell Investments Group first reported a position in ORIC in Q3 2021 and has held it in 8 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Russell Investments Group held 263,059 shares of Oric Pharmaceuticals worth $3.33M as of Q1 2026.
  • Russell Investments Group bought 56,022 Oric Pharmaceuticals shares in Q1 2026, an estimated $636K.
  • Oric Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #1583 holding.
  • Russell Investments Group first reported a position in Oric Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.